Patents
Patents for C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group (62,587)
05/2002
05/16/2002US20020058681 Pyrazole ether derivatives as anti-inflammatory/analgesic agents
05/16/2002US20020058678 For therapy of diseases or pathological conditions involving inflammation such as chronic inflammatory diseases
05/16/2002US20020058652 Pharmaceutical compositions and methods for use
05/16/2002US20020058618 Method for the treatmennt or prevention of a disease mediated by the alpha-2B-adrenoceptor
05/16/2002DE10056312A1 New 1-(N-substituted amidoalkyl) bicyclic uracil derivatives useful as medicaments for treating ischemia or reperfusion damage, are poly-(ADP-ribose)-synthetase inhibitors
05/16/2002CA2428784A1 Oral pharmaceutical composition containing a block copolymer
05/16/2002CA2427350A1 Pyrimidine derivatives and their use as neuropeptide y receptor ligands
05/16/2002CA2421594A1 3-substituted oxindole beta 3 agonists
05/16/2002CA2421154A1 Peroxisome proliferator activated receptor alpha agonists
05/15/2002EP1204652A1 Novel succinate derivative compounds useful as cysteine protease inhibitors
05/15/2002EP1204645A2 Melanocortin-4 receptor binding compounds and methods of use thereof
05/15/2002EP1049694B1 Derivatives of benzoxadiazoles, benzothiadiazoles, benzotriazoles and quinoxalines
05/15/2002EP0778833B1 Endothelin receptor antagonists
05/15/2002EP0748314B1 Tetrasubstituted imidazole derivatives, method for preparing the same, use thereof as drugs, and pharmaceutical compositions containing the same
05/15/2002CN1349542A Heterocyclic compounds, intermediates thereof and elastase inhibitors
05/15/2002CN1349531A Cyanopyrroles as progesterone receptor agonists
05/15/2002CN1349528A Pyrimidine compounds
05/15/2002CN1349527A Substituted benzolactam compounds
05/15/2002CN1349525A Di-aryl acid derivatives as PPAR receptor ligands
05/15/2002CN1349521A Compounds and methods for treatment of asthma, allergy and inflammatory disorders
05/15/2002CN1349514A Pesticidal triazine derivatives
05/15/2002CN1349510A Cyclo-alkyl substituted benzimidazoles and their use as parp inhibitors
05/15/2002CN1349509A Heterocyclic urea and related compounds useful as anti-inflammatory agents
05/15/2002CN1349506A Heterocyclic compounds having effect of activating nicoting acetylchloine alpha 4 beta 2 receptor
05/15/2002CN1349500A 3,3-substituted indoline derivatives
05/15/2002CN1348956A Substituted diazacycloheptane compound, medicine composite contg. same and the use thereof
05/15/2002CN1084751C Palladium catalyzed indolization
05/15/2002CN1084750C Process for producing cefazolin
05/15/2002CN1084619C Process for preparing medicine composition
05/15/2002CN1084618C Use of serotonin antagonists (5HT3) for treatment disease
05/14/2002US6388091 In presence of a halosilane compound; crystallization, purification
05/14/2002US6388071 Alkynyl phenyl heteroaromatic glucokinase activators
05/14/2002US6387992 Heat, oxidation and light resistance
05/14/2002US6387941 Antiserotonine agents
05/14/2002US6387940 Heterocyclylmethyl-substituted pyrazole derivatives
05/14/2002US6387939 Plant safening agnets; fungicide
05/14/2002US6387938 Benzimidazole derivatives
05/14/2002US6387937 Indole derivatives
05/14/2002US6387926 Inhibitors of farnesyl protein transferase
05/14/2002US6387923 Antiproliferative agents; anticancer agents
05/14/2002US6387919 Substituted oxindole derivatives as protein tyrosine kinase and as protein serine/threonine kinase inhibitors
05/14/2002US6387915 Isoxazole-sulfonamide endothelin antagonists
05/14/2002US6387903 Inhibitors of prenyl-protein transferase
05/14/2002US6387900 3(5)-ureido-pyrazole derivatives process for their preparation and their use as antitumor agents
05/14/2002US6387898 Treatment for CNS injuries
05/10/2002WO2002036597A1 Tricyclic derivatives of indole with antiangiogenic activity
05/10/2002WO2002036576A1 Phthalazinone derivatives
05/10/2002WO2002036575A1 Tagging compounds and process for use in aida libraries
05/10/2002WO2002036564A1 Sulfonylamino substituted 3-(aminomethylide)-2-indolinones as cell proliferation inhibitors
05/10/2002WO2002036562A2 1-aryl- or 1-alkylsulfonyl-heterocyclylbenzazoles as 5-hydroxytryptamine-6 ligands
05/10/2002WO2002036558A2 Novel crystal and solvate forms of ondansetron hydrochloride and processes for their preparation
05/10/2002WO2002036162A2 Compositions for treatment of ocular neovascularization and neural injury
05/10/2002WO2002036119A1 Δ2,-1,2,3-triazoline anticonvulsants and their active metabolite analogues, the aminoalkylpyridines, are excitatory amino acid antagonists and antiischemic agents, useful in the treatment of cerebral ischemia resulting from stroke
05/10/2002WO2002036116A2 Tripeptidyl peptidase inhibitors
05/10/2002WO2002036073A2 Receptor antagonist-lipid conjugates and delivery vehicles containing same
05/10/2002WO2002020437A3 Basic compounds containing tertiary amides with activity on tachykinin receptors, and pharmaceutical compositions containing them
05/10/2002WO2002018349A3 Process and intermediates for preparing retroviral protease inhibitors
05/10/2002WO2002008200A3 Arylethene-sulfonamides, their preparation and their use as endothelin antagonists
05/10/2002WO2001070706A3 4-oxo-1,4-dihydro-3-cinnolinecarboxamides as antiviral agents
05/10/2002WO2001038324A3 Imidazole derivatives and their use as raf kinase inhibitors
05/10/2002WO2001024827A3 INHIBITORS OF THE ENDOTHELIN SIGNALLING PATHWAY AND αVβ3 INTEGRIN RECEPTOR ANTAGONISTS FOR COMBINATION THERAPY
05/10/2002CA2427568A1 Tricyclic derivatives of indole with antiangiogenic activity
05/10/2002CA2426026A1 Novel crystal and solvate forms of ondansetron hydrochloride and processes for their preparation
05/09/2002US20020055632 Such as (3R,5S)-1-pyrimidin-2-yl-5-(2,4,5-trifluoro-benzyloxymethyl)-pyrrolidine-3 -thiol trifluoro-acetate useful as inhibitors of metalloproteases for treating diseases associated with vasoconstriction
05/09/2002US20020055522 Treatment of thrombotic diseases, asthma, emphysema, cirrhosis, arthritis, carcinoma, melanoma, restenois, atheroma, trauma, shock and reperfusion injury.
05/09/2002US20020055519 2-cyclohexyl imidazopyridine NMDA/NR2B antagonists
05/09/2002US20020055516 Nitrogen-containing heterocyclic compounds and medicaments containing the compounds
05/09/2002US20020055507 Ureas and thioureas inhibit production of cytokines
05/09/2002US20020055469 Anticoagulants
05/09/2002US20020055437 Stability of liquid formulations of various pesticides can be enhanced by utilizing quaternary ammoniuim salts
05/09/2002US20020055071 Antisoilants; reduce staining due to the residue of sensitizing dyess occuring during processing; antideposit agents; free of deposition of precipitates during low-temperature storage; storage stability; digital cameras
05/08/2002EP1203767A1 Heterocyclic-substituted alkylamide acat inhibitors
05/08/2002EP1203766A2 Carboxylic acid derivatives that inhibit the binding of integrins to their receptors
05/08/2002EP1202990A2 Neurotrophic pyrrolidines and piperidines, and related compositions containing them
05/08/2002EP1202989A1 Benzamide derivatives
05/08/2002EP1202988A2 Novel integrin receptor antagonists
05/08/2002EP1202976A1 Pyrazinones, compositions containing such compounds
05/08/2002EP1202975A1 Substituted polycyclic aryl and heteroaryl pyrazinones useful for selective inhibition of the coagulation cascade
05/08/2002EP1202734A1 3(5)-ureido-pyrazole derivatives, process for their preparation and their use as antitumor agents
05/08/2002EP1202733A1 3(5)-amino-pyrazole derivatives, process for their preparation and their use as antitumor agents
05/08/2002CN1348449A Heteroaryl diazacycloalkanes, their preparation and use
05/08/2002CN1348363A Novel pharmaceutical salt form
05/08/2002CN1347881A 法呢基蛋白转移酶抑制剂 Farnesyl protein transferase inhibitor
05/08/2002CN1347875A Novel cyclobutene diketone compound and its producing process, and pharmaceutical composition containing the same compound
05/07/2002US6384232 Radiology, hypoxic tissue cytotoxins, radiosensitizers; react n-(2,3-epoxypropyl)phthalimide with 2-nitro-imidazole; 6-((2-nitro-1h-imidazol-1-yl)methyl)-5-oxa-4,8-diaza undecane-2,10-dione dioxime compounds
05/07/2002US6384222 N-benzenesulfonyl-L-proline compounds, preparation method and method for using the compounds in therapy
05/07/2002US6384042 Systemic use of 5-HT3 receptor antagonists against rheumatic inflammatory processes
05/07/2002US6384032 Inhibitors of IL-12 production
05/07/2002CA2098612C Arthropodicidal carboxanilides
05/02/2002WO2002034744A1 Quinazoline derivatives
05/02/2002WO2002034743A1 Triazole derivatives and pharmaceutical compositions comprising them
05/02/2002WO2002034742A1 Aziridinylquinolinedione derivatives and process for their preparation
05/02/2002WO2002034726A2 Pyrimidine-2,4,6-trione metalloproteinase inhibitors
05/02/2002WO2002034725A1 Substituted phenyluracils
05/02/2002WO2002034718A1 Amide derivatives as nmda receptor antagonists
05/02/2002WO2002034716A2 Pyrrolidine modulators of ccr5 chemokine receptor activity
05/02/2002WO2002034263A1 Preventives/remedies for portal hypertension
05/02/2002WO2002005822A3 Compositions containing therapeutically active components having enhanced solubility
05/02/2002WO2001081305A3 Methylation of indole compounds using dimethy carbonate
05/02/2002WO2001024828A3 MODULATORS OF CYTOKINE MEDIATED SIGNALLING PATHWAYS AND INTEGRIN αVβ3 RECEPTOR ANTAGONISTS FOR COMBINATION THERAPY